TY - JOUR
T1 - Postoperative recovery profile after elective abdominal hysterectomy
T2 - a prospective, observational study of a multimodal anaesthetic regime
AU - Jensen, Kenneth
AU - Kehlet, Henrik
AU - Lund, Claus M
PY - 2009/5
Y1 - 2009/5
N2 - BACKGROUND AND OBJECTIVE: To evaluate the applicability, effectiveness, immediate postoperative complaints and requirements for a postanaesthesia care unit stay after elective abdominal hysterectomy under a well defined, multimodal anaesthetic regime.METHODS: Observational study of 145 consecutive patients scheduled for the procedure at a major university hospital in Denmark. Perioperative treatments and postoperative complaints were recorded continuously until discharge from the postanaesthesia care unit. Main outcome measures were treatment regimen adherence, pain, nausea and vomiting, respiratory insufficiency and time of discharge readiness.RESULTS: The structured regime consisting of total intravenous anaesthesia (propofol-remifentanil), well defined fluid administration, prophylactic antiemetics (dexamethasone, ondansetron, droperidol), weak analgesics (celecoxib, paracetamol) and intraoperative epidural analgesia (bupivacaine, morphine) was feasible in more than 90% of all patients. In the postanaesthesia care unit, 64% did not require opioids, but 25% experienced severe pain. Mean length of stay was 2 h with a mean discharge readiness of 80 min. Half the patients required supplemental oxygen for 1 h or more to sustain an SpO2 greater than 92%, and 8% experienced nausea or vomiting. A complicated recovery, defined as the presence of severe complaints (pain, nausea or vomiting), with more than five treatment interventions in the postanaesthesia care unit, or a length of stay more than 2 h, was seen in 52%.CONCLUSION: We conclude that a structured multimodal anaesthetic regime is feasible in daily clinical practice and advantageous, and that postoperative pain and oxygen requirements (to sustain an SpO2 >92%) are the major determinants for length of stay in the postanaesthesia care unit. Further research should focus on nonopioid analgesic systemic adjuvants to improve early recovery and reduce stay in the postanaesthesia care unit.
AB - BACKGROUND AND OBJECTIVE: To evaluate the applicability, effectiveness, immediate postoperative complaints and requirements for a postanaesthesia care unit stay after elective abdominal hysterectomy under a well defined, multimodal anaesthetic regime.METHODS: Observational study of 145 consecutive patients scheduled for the procedure at a major university hospital in Denmark. Perioperative treatments and postoperative complaints were recorded continuously until discharge from the postanaesthesia care unit. Main outcome measures were treatment regimen adherence, pain, nausea and vomiting, respiratory insufficiency and time of discharge readiness.RESULTS: The structured regime consisting of total intravenous anaesthesia (propofol-remifentanil), well defined fluid administration, prophylactic antiemetics (dexamethasone, ondansetron, droperidol), weak analgesics (celecoxib, paracetamol) and intraoperative epidural analgesia (bupivacaine, morphine) was feasible in more than 90% of all patients. In the postanaesthesia care unit, 64% did not require opioids, but 25% experienced severe pain. Mean length of stay was 2 h with a mean discharge readiness of 80 min. Half the patients required supplemental oxygen for 1 h or more to sustain an SpO2 greater than 92%, and 8% experienced nausea or vomiting. A complicated recovery, defined as the presence of severe complaints (pain, nausea or vomiting), with more than five treatment interventions in the postanaesthesia care unit, or a length of stay more than 2 h, was seen in 52%.CONCLUSION: We conclude that a structured multimodal anaesthetic regime is feasible in daily clinical practice and advantageous, and that postoperative pain and oxygen requirements (to sustain an SpO2 >92%) are the major determinants for length of stay in the postanaesthesia care unit. Further research should focus on nonopioid analgesic systemic adjuvants to improve early recovery and reduce stay in the postanaesthesia care unit.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Analgesics/administration & dosage
KW - Anesthesia Recovery Period
KW - Anesthetics, Combined/administration & dosage
KW - Anesthetics, Intravenous/therapeutic use
KW - Antiemetics/therapeutic use
KW - Cohort Studies
KW - Denmark
KW - Elective Surgical Procedures/methods
KW - Female
KW - Hospitals, University
KW - Humans
KW - Hysterectomy/methods
KW - Length of Stay
KW - Middle Aged
KW - Oxygen/administration & dosage
KW - Pain, Postoperative/drug therapy
KW - Piperidines/therapeutic use
KW - Postoperative Nausea and Vomiting/prevention & control
KW - Propofol/therapeutic use
KW - Prospective Studies
KW - Remifentanil
U2 - 10.1097/EJA.0b013e32831f3429
DO - 10.1097/EJA.0b013e32831f3429
M3 - Journal article
C2 - 19337129
SN - 0265-0215
VL - 26
SP - 382
EP - 388
JO - European Journal of Anaesthesiology
JF - European Journal of Anaesthesiology
IS - 5
ER -